The term fibromyalgia describes a complex syndrome characterized by pa
in amplification, musculoskeletal discomfort, and systemic symptoms. A
lthough its existence has been controversial, nearly all rheumatologis
ts now accept fibromyalgia as a distinct diagnostic entity. In fact, i
n the United States it is the third or fourth most common reason for r
heumatology referral. Exciting new insights into the aetiology, pathog
enesis, diagnosis and treatment of fibromyalgia will be reviewed.